|
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company spans across the globe and maintains offices, R&D centers, and production bases in more than 15 different cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes.
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company spans across the globe and maintains offices, R&D centers, and production bases in more than 15 different cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes.
|
|
|
Business Scope: Biotechnology development, technical consulting, technology transfer, and technical services; economic information consulting (excluding projects subject to administrative licensing); engineering bidding and tendering agency services; import and export of goods, import and export of technologies, and import and export agency services; sales of metal materials, chemical products (excluding Category I precursor chemicals and hazardous chemicals), and glass containers; conference services; organization of exhibitions and display activities; design, production, agency, and publication of advertisements; production of recombinant proteins; production of culture media and chromatography resins; production of biological reagent kits. (The market entity shall independently choose business projects and carry out business activities in accordance with the law. Projects subject to approval according to law shall be conducted after approval by relevant authorities and in accordance with the approved scope. The company shall not engage in business activities prohibited or restricted by national or local industrial policies.) Type of Enterprise: Public Company Location: United States South Korea United Kingdom Germany Switzerland Founded Date: 2010-07-22 |
|
- Kits(14)
- TARGET ENZYMES(22)
- TME(46)
- FCRS(20)
- SERUMALBUMINS(5)
- CMC(61)
- FLAG(23)
- CKP(53)
- SERVICE(5)
- CD3(8)
- TR-FRET Kits(2)
- CMC-MANUFACTURING(1)
- CD&BIOMARKERS(39)
- Agonist(23)
- SA(5)
- ANEURO(16)
- SIGNAL TRANSDUCTION(13)
- ADC(64)
- Virus(6)
- TOOL ENZYMES(3)
- GMP(1)
- ISOTYPE CONTROLS(9)
- CAR-T(51)
- SARS-CoV-2(6)
- CYTOKINE TARGETS(111)
- RECEPTOR(34)
| Country: | United States |
|---|---|
| Tel: | |
| Mobile: | +8615754881728 |
| E-mail: | yingjuan.dong@acrobiosystems.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 1 Innovation Way, Newark, DE, 19711, USA |









